Cameco Corp (CCO)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 113.88 |
|---|---|
| 52-week range | 109.68 – 182.72 |
| Return, 1 month / 3 months | −12.3% / −5.0% |
| Return, 1 year / 3 years | −10.9% / +130.4% |
| Trend | Below its 200-day average |
| RSI (14) | 35 |
| Volatility (1 year) | 53.6% |
| Worst drawdown (1 year) | -37.3% |
| Average daily value traded | 128.89M CAD |
| Dividend yield | 0.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cameco is a Canadian uranium company based in Saskatoon, Saskatchewan. It mines uranium ore at sites in northern Saskatchewan and refines and converts uranium at facilities in Ontario. The company supplies uranium and fuel services, including conversion and fuel fabrication, to nuclear utilities that operate power reactors. Its customers are electricity generators and other users of nuclear fuel in markets around the world, and its activities span mining, refining, conversion and the manufacture of fuel products for reactor operators.
Cameco Corp trades under the code CCO on the Toronto Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cameco Corp (CCO) trades on the Toronto Exchange in Canada. It last closed at CAD 113.88 on 19 October 2026.
Its price-based Market X-Ray is 38 out of 100 (a weak price profile), ranking 631 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.9% and over the last three months it fell 5.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 19 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -22.2% | ||
| From 52-week high | -37.3% | ||
| Momentum | 30 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.0% | ||
| 6-month return | -31.1% | ||
| 12-month return, skipping the last month | 1.6% | ||
| Stability (higher is calmer) | 38 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 53.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.3% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 128.89M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 17 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −9.3% |
|---|---|
| 1 month | −12.3% |
| 3 months | −5.0% |
| 6 months | −31.1% |
| 1 year | −10.9% |
| 3 years | +130.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 131.37 / 146.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 4.82 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Dec 2025 | CAD 0.2400 |
| 27 Nov 2024 | CAD 0.1600 |
| 29 Nov 2023 | CAD 0.1200 |
| 29 Nov 2022 | CAD 0.1200 |
| 29 Nov 2021 | CAD 0.0800 |
| 27 Nov 2020 | CAD 0.0800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.